DK1227859T3 - Neurophilinligander til behandling af okulære tilstande - Google Patents

Neurophilinligander til behandling af okulære tilstande

Info

Publication number
DK1227859T3
DK1227859T3 DK00980231T DK00980231T DK1227859T3 DK 1227859 T3 DK1227859 T3 DK 1227859T3 DK 00980231 T DK00980231 T DK 00980231T DK 00980231 T DK00980231 T DK 00980231T DK 1227859 T3 DK1227859 T3 DK 1227859T3
Authority
DK
Denmark
Prior art keywords
treatment
ocular conditions
neurophilin ligands
neurophilin
ligands
Prior art date
Application number
DK00980231T
Other languages
Danish (da)
English (en)
Inventor
Abdelmoula Namil
Iok-Hou Pang
Mark A Hellberg
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1227859T3 publication Critical patent/DK1227859T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00980231T 1999-11-12 2000-10-24 Neurophilinligander til behandling af okulære tilstande DK1227859T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16513799P 1999-11-12 1999-11-12

Publications (1)

Publication Number Publication Date
DK1227859T3 true DK1227859T3 (da) 2006-12-11

Family

ID=22597584

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00980231T DK1227859T3 (da) 1999-11-12 2000-10-24 Neurophilinligander til behandling af okulære tilstande

Country Status (16)

Country Link
US (1) US20060083774A1 (es)
EP (1) EP1227859B1 (es)
JP (1) JP2003514015A (es)
AR (1) AR034103A1 (es)
AT (1) ATE335524T1 (es)
AU (1) AU784347B2 (es)
BR (1) BR0015486A (es)
CA (1) CA2386579A1 (es)
CY (1) CY1106232T1 (es)
DE (1) DE60029985T2 (es)
DK (1) DK1227859T3 (es)
ES (1) ES2269206T3 (es)
HK (1) HK1046108B (es)
PT (1) PT1227859E (es)
TW (1) TW200511984A (es)
WO (1) WO2001035948A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021178977A1 (en) * 2020-03-06 2021-09-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions and methods for treating ocular disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260059A (en) * 1989-04-14 1993-11-09 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5798355A (en) * 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5840736A (en) * 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
US5846979A (en) * 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
ATE238792T1 (de) * 1998-02-23 2003-05-15 Fujisawa Pharmaceutical Co Verwendung von makroliden zur behandlung von glaukom
AU5555699A (en) * 1998-08-14 2000-03-06 Gpi Nil Holdings, Inc. Compositions and uses for vision and memory disorders
US6399648B1 (en) * 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders

Also Published As

Publication number Publication date
EP1227859B1 (en) 2006-08-09
DE60029985D1 (de) 2006-09-21
TW200511984A (en) 2005-04-01
DE60029985T2 (de) 2007-02-01
CA2386579A1 (en) 2001-05-25
WO2001035948A3 (en) 2002-01-17
AU784347B2 (en) 2006-03-16
HK1046108B (zh) 2007-01-05
AU1752201A (en) 2001-05-30
PT1227859E (pt) 2006-12-29
CY1106232T1 (el) 2011-06-08
HK1046108A1 (en) 2002-12-27
ATE335524T1 (de) 2006-09-15
US20060083774A1 (en) 2006-04-20
EP1227859A2 (en) 2002-08-07
ES2269206T3 (es) 2007-04-01
AR034103A1 (es) 2004-02-04
WO2001035948A2 (en) 2001-05-25
JP2003514015A (ja) 2003-04-15
BR0015486A (pt) 2002-07-02

Similar Documents

Publication Publication Date Title
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
ATE267566T1 (de) Hornhautlinse
FI20000863A (fi) Uusi hoitomenetelmä
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
DK1353694T3 (da) Kombinationer af ezetimibe med aspirin til behandling af vaskulære tilstande
DE60024934D1 (de) Optischer Filter
DK1176964T3 (da) Brug af ET743 til behandling af cancer
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
ATE298569T1 (de) Virus behandlung
DE69902986T2 (de) Infusionsfilter
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DE60007475D1 (de) Filter
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DK1227859T3 (da) Neurophilinligander til behandling af okulære tilstande
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
FI4299U1 (fi) Saunasuodatin
DK1493442T3 (da) Reboxetin til behandling af perifer neuropati
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser